On July 12th, Gelonhui reported that Santen Pharmaceutical (688117.SH) held the 21st meeting of the fourth board of directors and the 20th meeting of the fourth supervisory board on July 12, 2024 and approved the proposal on the delay of some raised investment projects. Considering the progress of the implementation of some raised investment projects (hereinafter referred to as "raised investment projects"), the company agreed to postpone the date when the raised investment project "formulation industrialization technology transformation project" reaches the planned usable status to June 2025.
圣诺生物(688117.SH)：拟将募投项目“制剂产业化技术改造项目”延期至2025年6月
Shengnuo Biotechnology (688117.SH): Plans to extend the "Formulation Industrialization Technology Renovation Project" of the fundraising project to June 2025.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.